Literature DB >> 3691294

Electrophysiological findings in familial exudative vitreoretinopathy.

H Ohkubo1, T Tanino.   

Abstract

Three patients in a family with familial exudative vitreoretinopathy (FEVR) were studied especially electrophysiologically. Two cases showed abnormal ERG, namely reduction of amplitude of oscillatory potentials, a and b wave of bright white flash ERG, scotopic and photopic b waves. One case showed reduced Light peak/Dark trough ratio of EOG. Next, the electrophysiological findings of cases with FEVR reported in the literature were analyzed. The result was that FEVR has electrophysiological varieties but a statistical significant relationship between electrophysiological findings and visual acuity. That is, cases with abnormal ERG or EOG have more impaired visual acuity than normal ones. Furthermore, there was a tendency that eyes with abnormal ERG or EOG showed more disturbed color vision and advanced fundus findings than normal ones. These results seemed to be understandable by anatomically characteristic fundus feature of FEVR.

Entities:  

Mesh:

Year:  1987        PMID: 3691294     DOI: 10.1007/bf00143048

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  9 in total

1.  Familial exudative vitreo-retinopathy.

Authors:  J Dudgeon
Journal:  Trans Ophthalmol Soc U K       Date:  1979-04

2.  Familial exudative vitreoretinopathy.

Authors:  V G Criswick; C L Schepens
Journal:  Am J Ophthalmol       Date:  1969-10       Impact factor: 5.258

3.  Flourescein angiography in mild stages of dominant exudative vitreoretinopathy.

Authors:  F A Nijhuis; A F Deutman; A L Aan de Kerk
Journal:  Mod Probl Ophthalmol       Date:  1979

4.  Familial exudative vitreoretinopathy. An expanded view.

Authors:  J Gow; G L Oliver
Journal:  Arch Ophthalmol       Date:  1971-08

5.  Autosomal dominant exudative vitreoretinopathy.

Authors:  E L Feldman; J L Norris; G W Cleasby
Journal:  Arch Ophthalmol       Date:  1983-10

6.  [Familial exudative vitreoretinopathy, rhegmatogenous retinal detachment and postoperative uveitis with massive subretinal exudation].

Authors:  Y Okubo; A Okubo; T Kubono; H Shimizu
Journal:  Nippon Ganka Gakkai Zasshi       Date:  1984-08

7.  Dominant exudative vitreoretinopathy and other vascular developmental disorders of the peripheral retina.

Authors:  C E van Nouhuys
Journal:  Doc Ophthalmol       Date:  1982-09-23       Impact factor: 2.379

8.  Familial exudative vitreoretinopathy.

Authors:  H Laqua
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1980

9.  Peripheral proliferative retinopathy without oxygen therapy in a full-term infant.

Authors:  J Schulman; L M Jampol; H Schwartz
Journal:  Am J Ophthalmol       Date:  1980-10       Impact factor: 5.258

  9 in total
  5 in total

1.  Familial exudative vitreoretinopathy.

Authors:  W E Benson
Journal:  Trans Am Ophthalmol Soc       Date:  1995

2.  Next-generation sequencing analysis of gene regulation in the rat model of retinopathy of prematurity.

Authors:  Rachel M Griffith; Hu Li; Nan Zhang; Tara L Favazza; Anne B Fulton; Ronald M Hansen; James D Akula
Journal:  Doc Ophthalmol       Date:  2013-06-18       Impact factor: 2.379

3.  Revesz syndrome with bilateral retinal detachments successfully treated by pars plana vitrectomy.

Authors:  Mamika Asano; Shoko Tsukamoto; Koh-Hei Sonoda; Hiroyuki Kondo
Journal:  Am J Ophthalmol Case Rep       Date:  2021-06-16

4.  Electroretinographic effects of retinal dragging and retinal folds in eyes with familial exudative vitreoretinopathy.

Authors:  Yukari Yaguchi; Satoshi Katagiri; Yoko Fukushima; Tadashi Yokoi; Sachiko Nishina; Mineo Kondo; Noriyuki Azuma
Journal:  Sci Rep       Date:  2016-07-26       Impact factor: 4.379

5.  Retinal Features of Family Members With Familial Exudative Vitreoretinopathy Caused By Mutations in KIF11 Gene.

Authors:  Hiroyuki Kondo; Itsuka Matsushita; Tatsuo Nagata; Etsuko Fujihara; Katsuhiro Hosono; Eiichi Uchio; Yoshihiro Hotta; Shunji Kusaka
Journal:  Transl Vis Sci Technol       Date:  2021-06-01       Impact factor: 3.283

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.